Federal Register / Vol. 75, No. 206 / Tuesday, October 26, 2010 / Notices 65657 

Section 6(b) of the Act on July 15, 2009 

(74 FR 34364). 

The last notification was filed with 

the Department on July 13, 2010. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on August 18, 2010 (75 FR 51114). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 2010–26740 Filed 10–25–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—International SAE 

Consortium Ltd. 

Notice is hereby given that, on 

September 21, 2010, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

International SAE Consortium Ltd. 

(‘‘ISAEC’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Amgen, Inc., Thousand 

Oaks, CA; AstraZeneca UK Ltd., 

London, United Kingdom; Cerner 

Corporation, Kansas City, MO; Clinical 

Data, Inc., Newton, MA; and Merck 

Sharp & Dohme Corp., Rahway, NJ, has 

been added as parties to this venture. 

Also, F. Hoffmann-La Roche, INC., 

Basel, Switzerland; Johnson & Johnson 

Pharmaceutical Research & 

Development, LLC, Raritan, NJ; and 

Sanofi-Aventis, Bridgewater, NJ, have 

withdrawn as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and ISAEC 

intends to file additional written 

notification disclosing all changes in 

membership. 

On September 27, 2007, ISAEC filed 

its original notification pursuant to 

Section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on November 7, 2007 

(72 FR 62867). 

The last notification was filed with 

the Department of Justice on May 21, 

2008. A notice was published in the 

Federal Register pursuant to Section 

6(b) of the Act on June 27, 2008 (73 FR 

36571). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 2010–26737 Filed 10–25–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—ASTM International 

Notice is hereby given that, on 

September 23, 2010, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), ASTM 

International (‘‘ASTM’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing additions or 

changes to its standards development 

activities. The notifications were filed 

for the purpose of extending the Act’s 

provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, ASTM has provided an 

updated list of current, ongoing ASTM 

standards activities originating between 

May 2010 and September 2010 

designated as work items. A complete 

listing of ASTM work items, along with 

a brief description of each, is available 

at http://www.astm.org. 

On September 15, 2004, ASTM filed 

its original notification pursuant to 

Section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on November 10, 2004 

(69 FR 65226). 

The last notification was filed with 

the Department on May 6, 2010. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 1, 2010 (75 FR 30440). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 2010–26736 Filed 10–25–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Alliance for Water 

Stewardship 

Notice is hereby given that, on 

September 10, 2010, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Alliance for Water Stewardship (‘‘AWS’’) 

has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to Section 6(b) of the Act, 

the name and principal place of 

business of the standards development 

organization is: Alliance for Water 

Stewardship, Arlington, VA. The nature 

and scope of AWS’s standards 

development activities are: (1) To 

establish equitable, voluntary, 

transparent, science-based standards for 

socially beneficial and environmentally 

sustainable use and management of 

fresh water at the watershed level; (2) to 

promote use and management of fresh 

water which will maintain or improve 

biodiversity and ecological processes 

and secure longterm benefits for local 

peoples and society at large; and (3) to 

encourage effective governance for 

water use and management through 

voluntary certification of businesses and 

water service providers. The AWS is 

responsible for coordinating and 

overseeing the process of developing 

water use and management target 

standards and indicators, such as 

catchment flow volume, user 

abstraction, nutrients in effluents, 

sediments in effluents, temperature of 

effluents, water pricing, and other 

aspects of a voluntary water 

stewardship standard system. As part of 

its standards development activities, the 

AWS organizes a Global Water 

Roundtable and continent-level 

Regional Initiatives, through which it 

invites stakeholder organizations to 

participate in the standards 

development process. The AWS will 

hold the intellectual property resulting 

from its standards development 

activities until such a time when it may 


emcdonald on DSK2BSOYB1PROD with NOTICES
65658 Federal Register / Vol. 75, No. 206 / Tuesday, October 26, 2010 / Notices 

transfer its holdings to a successor 

organization or is itself designated the 

permanent custodian of the intellectual 

property. 

Below is the name and contact 

information of an individual from 

whom additional information 

concerning the organization can be 

obtained: Carey R. Ramos, Esq.; Paul, 

Weiss, Rifkind, Wharton & Garrison 

LLP; 1285 Avenue of the Americas; New 

York, NY 10019–6064. 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 2010–26734 Filed 10–25–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled 

Substances;Notice of Application 

This is notice that on July 22, 2010, 

Cody Laboratories Inc., 601 Yellowstone 

Avenue, Cody, Wyoming 82414–9321, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) for registration as an importer of 

the basic classes of controlled 

substances listed in schedule II: 

Drug Schedule 

Raw Opium (9600) ....................... II 

Concentrate of Poppy Straw 

(9670).

II 

The company plans to import narcotic 

raw materials for manufacturing and 

further distribution to its customers. 

The company is registered with DEA as 

a manufacturer of several controlled 

substances that are manufactured from 

raw opium, poppy straw, and 

concentrate of poppy straw. 

As explained in the Correction to 

Notice of Application pertaining to 

Rhodes Technologies, 72 FR 3417 

(2007), comments and requests for 

hearings on applications to import 

narcotic raw material are not 

appropriate. 

As noted in a previous notice 

published in the Federal Register on 

September 23, 1975, (40 FR 43745), all 

applicants for registration to import a 

basic class of any controlled substances 

in schedule I or II are, and will continue 

to be, required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: October 19, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator,Office of 

Diversion Control,Drug Enforcement 

Administration. 

[FR Doc. 2010–27023 Filed 10–25–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to Title 21 Code of Federal 

Regulations 1301.34(a), this is notice 

that on July 12, 2010, Noramco, Inc., 

Division of Ortho-McNeil, Inc., 500 

Swedes Landing Road, Wilmington, 

Delaware 19801, made application by 

renewal to the Drug Enforcement 

Administration (DEA) for registration as 

an importer of the basic classes of 

controlled substances listed in schedule 

II: 

Drug Schedule 

Raw Opium (9600) ....................... II 

Concentrate of Poppy Straw 

(9670).

II 

Tapentadol (9780) ........................ II 

The company plans to import the Raw 

Opium (9600) and Concentrate of Poppy 

Straw (9670) to manufacture other 

controlled substances. The company 

plans to import Tapentadol (9780) in 

intermediate form for the bulk 

manufacture of Tapentadol (9780) 

which it will distribute to its customers. 

No comments, objections, or requests 

for any hearings will be accepted on any 

application for registration or reregistration to import crude opium, 

poppy straw, concentrate of poppy 

straw, and coca leaves. As explained in 

the Correction to Notice of Application 

pertaining to Rhodes Technologies, 72 

FR 3417 (2007), comments and requests 

for hearings on applications to import 

narcotic raw material are not 

appropriate. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic classes of controlled 

substances listed in schedule I or II, 

which fall under the authority of section 

1002(a)(2)(B) of the Act [21 U.S.C. 

952(a)(2)(B)] may, in the circumstances 

set forth in 21 U.S.C. 958(i), file 

comments or objections to the issuance 

of the proposed registration and may, at 

the same time, file a written request for 

a hearing on such application pursuant 

to 21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than November 26, 2010. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substances in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 

21U.S.C. 958(a); 21 U.S.C. 823(a); and 

21 CFR 1301.34(b), (c), (d), (e), and (f) 

are satisfied. 

Dated: October 19, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator,Office of 

Diversion Control,Drug Enforcement 

Administration. 

[FR Doc. 2010–27025 Filed 10–25–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on July 12 2010, 

Aldrich Chemical Company Inc., DBA 

Isotec, 3858 Benner Road, Miamisburg, 

Ohio 45342–4304, made application by 

renewal to the Drug Enforcement 

Administration (DEA) as a bulk 

manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Methaqualone (2565) ................... I 

Ibogaine (7260) ............................ I 

Tetrahydrocannabinols (7370) ..... I 

2,5–Dimethoxyamphetamine 

(7396).

I 

Psilocyn (7438) ............................. I 

Normorphine (9313) ..................... I 

Acetylmethadol (9601) ................. I 

Alphacetylmethadol except levo– 

alphacetylmethadol (9603).

I 

Normethadone (9635) .................. I 

Norpipanone (9636) ..................... I 

3–Methylfentanyl (9813) ............... I 


emcdonald on DSK2BSOYB1PROD with NOTICES